A biodegradable microneedle cuff for comparison of drug effects through perivascular delivery to balloon-injured arteries

Dae Hyun Kim, Eui Hwa Jang, Kang Ju Lee, Ji Yong Lee, Seung Hyun Park, Il Ho Seo, Kang Woog Lee, Seung Hyun Lee, WonHyoung Ryu, Young Nam Youn

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Restenosis at a vascular anastomosis site is a major cause of graft failure and is difficult to prevent by conventional treatment. Perivascular drug delivery has advantages as drugs can be diffused to tunica media and subintima while minimizing the direct effect on endothelium. This in vivo study investigated the comparative effectiveness of paclitaxel, sirolimus, and sunitinib using a perivascular biodegradable microneedle cuff. A total of 31 New Zealand white rabbits were used. Rhodamine was used to visualize drug distribution (n = 3). Sirolimus- (n = 7), sunitinib- (n = 7), and paclitaxel-loaded (n = 7) microneedle cuffs were placed at balloon-injured abdominal aortae and compared to drug-free cuffs (n = 7). Basic histological structures were not affected by microneedle devices, and vascular wall thickness of the device-only group was similar to that of normal artery. Quantitative analysis revealed significantly decreased neointima formation in all drug-treated groups (p < 0.001). However, the tunica media layer of the paclitaxel-treated group was significantly thinner than that of other groups and also showed the highest apoptotic ratio (p < 0.001). Proliferating cell nuclear antigen (PCNA)-positive cells were significantly reduced in all drug-treated groups. Sirolimus or sunitinib appeared to be more appropriate for microneedle devices capable of slow drug release because vascular wall thickness was minimally affected.

Original languageEnglish
Article number56
JournalPolymers
Volume9
Issue number2
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Balloons
Antigens
Drug delivery
Grafts
Cells
Sirolimus
Paclitaxel
Chemical analysis
Pharmaceutical Preparations
Rhodamines
Proliferating Cell Nuclear Antigen
sunitinib

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Polymers and Plastics

Cite this

Kim, D. H., Jang, E. H., Lee, K. J., Lee, J. Y., Park, S. H., Seo, I. H., ... Youn, Y. N. (2017). A biodegradable microneedle cuff for comparison of drug effects through perivascular delivery to balloon-injured arteries. Polymers, 9(2), [56]. https://doi.org/10.3390/polym9020056
Kim, Dae Hyun ; Jang, Eui Hwa ; Lee, Kang Ju ; Lee, Ji Yong ; Park, Seung Hyun ; Seo, Il Ho ; Lee, Kang Woog ; Lee, Seung Hyun ; Ryu, WonHyoung ; Youn, Young Nam. / A biodegradable microneedle cuff for comparison of drug effects through perivascular delivery to balloon-injured arteries. In: Polymers. 2017 ; Vol. 9, No. 2.
@article{6b478be87c8246aea772a13a4ad0360b,
title = "A biodegradable microneedle cuff for comparison of drug effects through perivascular delivery to balloon-injured arteries",
abstract = "Restenosis at a vascular anastomosis site is a major cause of graft failure and is difficult to prevent by conventional treatment. Perivascular drug delivery has advantages as drugs can be diffused to tunica media and subintima while minimizing the direct effect on endothelium. This in vivo study investigated the comparative effectiveness of paclitaxel, sirolimus, and sunitinib using a perivascular biodegradable microneedle cuff. A total of 31 New Zealand white rabbits were used. Rhodamine was used to visualize drug distribution (n = 3). Sirolimus- (n = 7), sunitinib- (n = 7), and paclitaxel-loaded (n = 7) microneedle cuffs were placed at balloon-injured abdominal aortae and compared to drug-free cuffs (n = 7). Basic histological structures were not affected by microneedle devices, and vascular wall thickness of the device-only group was similar to that of normal artery. Quantitative analysis revealed significantly decreased neointima formation in all drug-treated groups (p < 0.001). However, the tunica media layer of the paclitaxel-treated group was significantly thinner than that of other groups and also showed the highest apoptotic ratio (p < 0.001). Proliferating cell nuclear antigen (PCNA)-positive cells were significantly reduced in all drug-treated groups. Sirolimus or sunitinib appeared to be more appropriate for microneedle devices capable of slow drug release because vascular wall thickness was minimally affected.",
author = "Kim, {Dae Hyun} and Jang, {Eui Hwa} and Lee, {Kang Ju} and Lee, {Ji Yong} and Park, {Seung Hyun} and Seo, {Il Ho} and Lee, {Kang Woog} and Lee, {Seung Hyun} and WonHyoung Ryu and Youn, {Young Nam}",
year = "2017",
month = "1",
day = "1",
doi = "10.3390/polym9020056",
language = "English",
volume = "9",
journal = "Polymers",
issn = "2073-4360",
publisher = "MDPI AG",
number = "2",

}

A biodegradable microneedle cuff for comparison of drug effects through perivascular delivery to balloon-injured arteries. / Kim, Dae Hyun; Jang, Eui Hwa; Lee, Kang Ju; Lee, Ji Yong; Park, Seung Hyun; Seo, Il Ho; Lee, Kang Woog; Lee, Seung Hyun; Ryu, WonHyoung; Youn, Young Nam.

In: Polymers, Vol. 9, No. 2, 56, 01.01.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A biodegradable microneedle cuff for comparison of drug effects through perivascular delivery to balloon-injured arteries

AU - Kim, Dae Hyun

AU - Jang, Eui Hwa

AU - Lee, Kang Ju

AU - Lee, Ji Yong

AU - Park, Seung Hyun

AU - Seo, Il Ho

AU - Lee, Kang Woog

AU - Lee, Seung Hyun

AU - Ryu, WonHyoung

AU - Youn, Young Nam

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Restenosis at a vascular anastomosis site is a major cause of graft failure and is difficult to prevent by conventional treatment. Perivascular drug delivery has advantages as drugs can be diffused to tunica media and subintima while minimizing the direct effect on endothelium. This in vivo study investigated the comparative effectiveness of paclitaxel, sirolimus, and sunitinib using a perivascular biodegradable microneedle cuff. A total of 31 New Zealand white rabbits were used. Rhodamine was used to visualize drug distribution (n = 3). Sirolimus- (n = 7), sunitinib- (n = 7), and paclitaxel-loaded (n = 7) microneedle cuffs were placed at balloon-injured abdominal aortae and compared to drug-free cuffs (n = 7). Basic histological structures were not affected by microneedle devices, and vascular wall thickness of the device-only group was similar to that of normal artery. Quantitative analysis revealed significantly decreased neointima formation in all drug-treated groups (p < 0.001). However, the tunica media layer of the paclitaxel-treated group was significantly thinner than that of other groups and also showed the highest apoptotic ratio (p < 0.001). Proliferating cell nuclear antigen (PCNA)-positive cells were significantly reduced in all drug-treated groups. Sirolimus or sunitinib appeared to be more appropriate for microneedle devices capable of slow drug release because vascular wall thickness was minimally affected.

AB - Restenosis at a vascular anastomosis site is a major cause of graft failure and is difficult to prevent by conventional treatment. Perivascular drug delivery has advantages as drugs can be diffused to tunica media and subintima while minimizing the direct effect on endothelium. This in vivo study investigated the comparative effectiveness of paclitaxel, sirolimus, and sunitinib using a perivascular biodegradable microneedle cuff. A total of 31 New Zealand white rabbits were used. Rhodamine was used to visualize drug distribution (n = 3). Sirolimus- (n = 7), sunitinib- (n = 7), and paclitaxel-loaded (n = 7) microneedle cuffs were placed at balloon-injured abdominal aortae and compared to drug-free cuffs (n = 7). Basic histological structures were not affected by microneedle devices, and vascular wall thickness of the device-only group was similar to that of normal artery. Quantitative analysis revealed significantly decreased neointima formation in all drug-treated groups (p < 0.001). However, the tunica media layer of the paclitaxel-treated group was significantly thinner than that of other groups and also showed the highest apoptotic ratio (p < 0.001). Proliferating cell nuclear antigen (PCNA)-positive cells were significantly reduced in all drug-treated groups. Sirolimus or sunitinib appeared to be more appropriate for microneedle devices capable of slow drug release because vascular wall thickness was minimally affected.

UR - http://www.scopus.com/inward/record.url?scp=85013675155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013675155&partnerID=8YFLogxK

U2 - 10.3390/polym9020056

DO - 10.3390/polym9020056

M3 - Article

AN - SCOPUS:85013675155

VL - 9

JO - Polymers

JF - Polymers

SN - 2073-4360

IS - 2

M1 - 56

ER -